Immunitybio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.83-$12.43
Market Cap
$7.5B
Shares Short
135M

Financials

See more
Revenue (12 Mos)
$113.2M
Revenue Growth (YoY)
407%
Gross Profit (12 Mos)
$112.5M
Diluted EPS
-$0.38

News

See more

Yahoo Finance • 2 days ago

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman

Yahoo Finance • 2 days ago

ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX

Yahoo Finance • 2 days ago

DEADLINE ALERT for SMCI, IBRX, and PINS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • 2 days ago

IBRX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ImmunityBio, Inc. Securities Lawsuit — The Gross Law Firm

About

CEO
Mr. Richard Gerald Adcock
Address
3530 John Hopkins Court, San Diego, CA, United States, 92121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
684